الرئيسية
أحدث الصور
التسجيل
دخول
The United States Food and Drug Administration has approved two new combination vaccines:
*Diphtheria, tetanus, acellular pertussis (DTaP), inactivated poliovirus (IPV), and Haemophilus influenzae type b: Pentacel
, approved for use in infants and children at 2, 4, 6, and 15 through 18 months of age .
*DTaP and IPV: Kinrix
, approved for the fifth dose of DTaP and the fourth dose of IPV at four to six years in children whose previous DTaP doses were with Infanrix or Pediarix or a combination of the two .
*Diphtheria, tetanus, acellular pertussis (DTaP), inactivated poliovirus (IPV), and Haemophilus influenzae type b: Pentacel
, approved for use in infants and children at 2, 4, 6, and 15 through 18 months of age .*DTaP and IPV: Kinrix
, approved for the fifth dose of DTaP and the fourth dose of IPV at four to six years in children whose previous DTaP doses were with Infanrix or Pediarix or a combination of the two .
» Diseases and Disorders in Infancy and Early Childhood
» كيفية التسجيل والإستعداد لامتحان ال Mccee الكندي
» MRCP 2 Practice Papers
» إمتحانات السنوات السابقة لل MRCP part 1
» oxford handbooks Series
» ادق برنامج عيادات لادارة عيادتك الخاصة
» لعلاج السحر والمس والعين
» للحصول على ( الزمالة البريطانية لطب الاطفال MRCPCH ) بكل سهولة من CONNECT CENTER
» الأن ولفترة محدووودة ( كورس زمالة الباطنة MRCP ) بارخص الاسعاااار من connect center